4//SEC Filing
Cragg David 4
Accession 0001061983-21-000247
CIK 0001061983other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 5:16 PM ET
Size
13.9 KB
Accession
0001061983-21-000247
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
Cragg David
V.P., Human Resources
Transactions
- Exercise/Conversion
Common Stock
2021-11-01$6.00/sh+6,675$40,050→ 145,379 total - Sale
Common Stock
2021-11-01$34.89/sh−6,675$232,888→ 138,704 total - Exercise/Conversion
Common Stock
2021-11-01$6.00/sh+18,325$109,950→ 157,029 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2021-11-01−18,325→ 0 totalExercise: $6.00From: 2013-04-05Exp: 2023-03-05→ Common Stock (18,325 underlying) - Sale
Common Stock
2021-11-01$34.89/sh−18,325$639,352→ 138,704 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-11-01−6,675→ 0 totalExercise: $6.00From: 2013-04-05Exp: 2023-03-05→ Common Stock (6,675 underlying)
Footnotes (3)
- [F1]Amount of securities beneficially owned following reported transaction has been adjusted by 1,541 shares purchased pursuant to ESPP but were not previously reported. Reporting persons Form 4 filed on 10/1/2021 erroneously stated that the reported 137,123 shares owned following reporting persons transaction on October 1, 2021 included 13,678 shares of common stock purchased pursuant to ESPP, but in fact only 12,137 shares of common stock purchased pursuant to ESPP were included in that 137,123 share total.
- [F2]Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021.
- [F3]Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.
Documents
Issuer
CYTOKINETICS INC
CIK 0001061983
Entity typeother
Related Parties
1- filerCIK 0001316459
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 5:16 PM ET
- Size
- 13.9 KB